10 articles tagged with #genomics. AI-curated summaries with sentiment analysis and key takeaways from 50+ sources.
Researchers developed a Neuro-Symbolic Agentic Framework combining machine learning with LLM-based reasoning to predict colorectal cancer drug responses. The system achieved significant predictive accuracy (r=0.504) and introduces 'Inverse Reasoning' for simulating genomic edits to predict drug sensitivity changes.
GeneZip is a new DNA compression model that achieves 137.6x compression with minimal performance loss by recognizing that genomic information is highly imbalanced. The system enables training of much larger AI models for genomic analysis using single GPU setups instead of expensive multi-GPU configurations.
NVIDIA has made Evo 2, the largest publicly available AI foundation model for genomic data, accessible through its BioNeMo platform. The model was developed in collaboration with Arc Institute and can understand genetic code across all domains of life, built on NVIDIA's DGX Cloud platform.
A new open-source AI model has been developed specifically for genomics, trained on trillions of DNA bases. The system can identify various genetic elements including genes, regulatory sequences, and splice sites, representing a significant advancement in AI-powered biological analysis.
Google DeepMind has launched AlphaGenome, an AI tool that analyzes the 98% of human DNA that doesn't code for proteins but regulates gene expression. The deep-learning platform can predict 11 types of biological signals and is already being used by thousands of scientists worldwide for cancer research, drug discovery, and synthetic DNA design.
DeepSomatic is an AI tool developed to identify genetic variants in tumor samples, advancing cancer research and precision medicine capabilities. This represents a significant application of artificial intelligence in healthcare diagnostics and genomic analysis.
AlphaGenome introduces a new unified DNA sequence model designed to improve regulatory variant-effect prediction and enhance understanding of genome function. The AI-powered genomics tool is now accessible through an API for researchers and developers.
NVIDIA CEO Jensen Huang participated in a fireside chat at the J.P. Morgan Healthcare Conference, discussing AI applications across healthcare sectors including genomic research, drug discovery, clinical trials, and patient care. The discussion highlighted how AI is making significant inroads throughout the entire healthcare industry.
Researchers developed UTR-STCNet, a new Transformer-based AI model that can analyze variable-length genetic sequences to predict protein translation efficiency. The model outperformed existing methods and can identify important regulatory elements in mRNA sequences, potentially advancing therapeutic mRNA design.
DeepPolisher represents a new AI-driven approach to genome polishing that significantly improves the accuracy of genomic sequencing data. This advancement could enhance the quality and reliability of genomic research foundations across various scientific and medical applications.
